INTELLIA THERAPEUTICS, INC. (NTLA) Net margin 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) net profit margin by fiscal year — reported net income divided by reported revenue.
-609.9%FY2025 · since FY2016: -192.0% → -609.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -609.9% | +286.9 pp |
| FY2024 | -896.8% | +429.7 pp |
| FY2023 | -1326.5% | -416.7 pp |
| FY2022 | -909.8% | -99.3 pp |
| FY2021 | -810.5% | -579.0 pp |
| FY2020 | -231.5% | +868.7 pp |
| FY2019 | -1100.1% | -819.7 pp |
| FY2018 | -280.4% | -21.8 pp |
| FY2017 | -258.6% | -66.7 pp |
| FY2016 | -192.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice